浪姐歌手对打

Pfizer cuts full-year outlook due to declining sales of Covid-19-related products_蜘蛛资讯网

venue for COVID-19-related products and inventory write-offs.That is short of the full-year revenue of $63.61 billion and earnings of $2.77 per share that Wall Street was expecting, and far short of t

arter, but Pfizer said in August that it expected a rebound in the second half of 2023. Shares of Pfizer slipped more than 1% before the opening bell Monday and Moderna, which is heavily reliant on th

当前文章：http://ml2.guandianke.cn/2ou/kz1mk0.html

发布时间：08:19:47